PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report)’s share price shot up 12.4% on Thursday . The company traded as high as $1.83 and last traded at $1.81. 129,298 shares traded hands during trading, an increase of 499% from the average session volume of 21,600 shares. The stock had previously closed at $1.61.
PharmaCyte Biotech Trading Up 12.4 %
The firm has a 50-day simple moving average of $1.61 and a 200-day simple moving average of $1.71. The firm has a market cap of $12.61 million, a P/E ratio of 3.42 and a beta of -0.18.
PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) last issued its quarterly earnings data on Friday, December 13th. The company reported ($0.29) earnings per share for the quarter.
About PharmaCyte Biotech
PharmaCyte Biotech, Inc, a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer.
Further Reading
- Five stocks we like better than PharmaCyte Biotech
- ESG Stocks, What Investors Should Know
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Most Volatile Stocks, What Investors Need to Know
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
